This analysis corroborated that both LPS and rhMIF alone can generate a different response between PBMC from CS and RA patients in the secretion of IL-25, IL-31, and IL-33, and that LPS in conjunction with rhMIF generates an additive effect on PBMC from both groups but no synergistic interaction (Table 1). The gene discussed is IL33; the disease is rheumatoid arthritis.